The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Central sympathetic overactivity: Maladies and mechanisms
Open accessAbstract
There is growing evidence to suggest that many disease states are accompanied by chronic elevations in sympathetic nerve activity. The present review will specifically focus on central sympathetic overactivity and highlight three main areas of interest: 1) the pathological consequences of excessive sympathetic nerve activity; 2) the potential role of centrally derived nitric oxide in the genesis of neural dysregulation in disease; and 3) the promise of several novel therapeutic strategies targeting central sympathetic overactivity. The findings from both animal and human studies will be discussed and integrated in an attempt to provide a concise update on current work and ideas in these important areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768 · cited 3×
“This can lead to abnormal wall to lumen ratio, increased resistance to flow and accelerate the progression of atherosclerosis (Failla et al., 1999; Folkow, 1982).”
BackgroundSomatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507 · cited 1×
“In humans, a comparable direct assessment of central sympathetic activity can be made using the microneurography technique to selectively record from postganglionic muscle or skin sympathetic nerves (Vallbo et al., 1979).”
MethodAortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1111 · Cited by 1,493 · cited 1×
“…between increased arterial stiffness and increased mortality rates in populations of patients where elevations in SNA are prevalent, such as hypertension (Blacher et al., 1999a), end stage renal disease (Blacher et al., 1999b; London et al., 2001) and type II diabetes (Cruickshank et al., 2002).”
BackgroundSympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132 · cited 1×
“…SNA is not isolated to diseases of the cardiovascular system and has also been reported in a plethora of other conditions including: kidney disease (Converse et al., 1992), type II diabetes mellitus (Huggett et al., 2003), obesity (Grassi et al., 2007), metabolic syndrome (Grassi et al., 2005),…”
BackgroundHyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Arterial wave reflections and survival in end-stage renal failure
London, G. M., Blacher, J., Pannier, B., Guérin, A. P., Marchais, S. J., & Safar, M. E. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.434 · Cited by 853
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Simpson, P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111023 · Cited by 618 · cited 1×
“Administration of sub-pressor doses of noradrenaline have been reported to have a direct trophic effect on cardiac myocytes and increase left ventricular mass and wall thickness in animals (Sen and Young, 1991; Simpson, 1983).”
BackgroundCOWLEY, A. W., LIARD, J. F., & GUYTON, A. C. (1973) · Circulation Research · doi:10.1161/01.res.32.5.564 · Cited by 593
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526 · cited 2×
“Furthermore, the degree of sympathetic overactivity has been found to be related to the magnitude of hypertension in cross-sectional patient studies (Grassi et al., 1998) and in longitudinal studies of spontaneously hypertensive rats (Judy et al., 1979).”
BackgroundZoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
How to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455 · cited 4×
“Assessment of SNA Experimental quantification of the activity of the sympathetic nervous system can be undertaken using several methodologies (Esler et al., 2003; Grassi, 1998; Grassi and Esler, 1999).”
BackgroundMethodInfluentialLoewy, A. D. (1990) · Central Regulation of Autonomic Functions · doi:10.1093/oso/9780195051063.003.0006 · Cited by 396
Sakuma, I., Togashi, H., Yoshioka, M., Saito, H., Yanagida, M., Tamura, M., Kobayashi, T., Yasuda, H., Gross, S. S., & Levi, R. (1992) · Circulation Research · doi:10.1161/01.res.70.3.607 · Cited by 384 · cited 2×
“The administration of NOS inhibitors by intravenous injection (Sakuma et al., 1992), intracisternal injection (el Karib et al.”
MethodLANDSBERG, L. (1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068066 · Cited by 373 · cited 1×
“Over two decades ago Landsberg proposed a link between the development of metabolic abnormalities, such as insulin resistance and dyslipidemia, and the activation of the sympathetic nervous system (Landsberg, 1986).”
BackgroundCentral Regulation of Autonomic Functions
(1990) · doi:10.1093/oso/9780195051063.001.0001 · Cited by 344
Parati, G., Mancia, G., Rienzo, M. D., & Castiglioni, P. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00446.2006 · Cited by 325
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension
Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., & Mary, D. A. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000103123.66264.fe · Cited by 305
Wallin, B. G., Esler, M., Dorward, P., Eisenhofer, G., Ferrier, C., Westerman, R., & Jennings, G. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019217 · Cited by 298
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., Hickie, I., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32829baae7 · Cited by 291
A central nervous system action of nitric oxide in blood pressure regulation
Togashi, H., Sakuma, I., Yoshioka, M., Kobayashi, T., Yasuda, H., Kitabatake, A., Saito, H., Gross, S. S., & Levi, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10757-x · Cited by 270 · cited 2×
“, 1992), intracisternal injection (el Karib et al., 1993; Togashi et al., 1992), or by direct injection into the RVLM (Zanzinger et al.”
MethodRelationship between central sympathetic activity and stages of human hypertension
Smith, P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.10.010 · Cited by 215 · cited 5×
“Indeed, there is compelling evidence that sympathetic activation plays a pathogenic role in triggering the essential hypertensive state (Abboud, 1982; Grassi, 1998; Grassi, 2004a; Grassi, 2004b; Smith et al., 2004), although this concept is not universally accepted (Joyner et al.”
BackgroundInfluentialBurns, J., Sivananthan, M. U., Ball, S. G., Mackintosh, A. F., Mary, D. A. S. G., & Greenwood, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.668863 · Cited by 122 · cited 1×
“it has recently been demonstrated in essential hypertensive patients that left ventricular hypertrophy, as determined using cardiac magnetic resonance imaging, is related to elevations in muscle SNA (Burns et al., 2007).”
BackgroundSTROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., & RITZ, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123602 · Cited by 112
Hausberg, M., Mark, A. L., Hoffman, R. P., Sinkey, C. A., & Anderson, E. A. (1995) · Journal of Hypertension · doi:10.1097/00004872-199509000-00012 · Cited by 90 · cited 2×
“In support of this contention, subsequent studies in healthy human volunteers demonstrated that infusions of insulin, with glucose concentrations clamped, increased muscle SNA, an effect which appeared to be independent of the vasodilatory effects of insulin (Anderson et al., 1991; Hausberg et al., 1995).”
BackgroundResultEl karib, A. O., Sheng, J., Betz, A. L., & Malvin, R. L. (1993) · Clinical and Experimental Hypertension · doi:10.3109/10641969309041644 · Cited by 48
Cited by
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 400
The sympathetic nervous system and blood pressure in humans: implications for hypertension
Fisher, J. P., & Paton, J. F. R. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2011.66 · Cited by 260
Self-citationA new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
Sano, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.12.004 · Cited by 188
Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
Kaur, J., Young, B., & Fadel, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081682 · Cited by 168
Self-citation
Metadata
- Authors
- Fisher, J. P., Young, C. N., & Fadel, P. J.
- Venue
- Autonomic Neuroscience
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 148
- Issue
- 1-2
- Pages
- 5-15
- ISSN
- 1566-0702 (ISSN-L)
- OpenAlex
- W2074718841
- Cited by
- 204
- References
- 31
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.